Avacta Group Share News (AVCT)

Monday broker round-up UPDATE

Avacta Group: Numis lowers target price from 2p to 1.6p retaining its buy recommendation. Braemer Shipping Services: Westhouse Securities reinstates with a target price of 545p and a buy recommendation. British Land: Liberum Capital upgrades to buy with a target price of 763p. Catlin Group: Deuts

Avacta Group Launches New OPTIM Variants As It seeks new Customers

UK MIDDAY BRIEFING: Smith & Nephew Confident In Outlook

UK WINNERS & LOSERS: Smith & Nephew, Rexam Lead Few FTSE 100 Risers

Friday broker round-up UPDATE

AstraZeneca: Deutsche Bank ups target price from 3950p to 4000p staying with its hold recommendation. Avacta: Numis places both its target price and its buy recommendation under review. Barclays: Berenberg upgrades from sell to hold with a target price of 220p. Bodycote: UBS shifts target price f

Avacta Group Falls On Sensipod Delays, North America Problems

Sector movers: Weak results, outlook from Glaxo sink pharma stocks

A slump in the share price of GlaxoSmithKline dragged the pharmaceuticals and biotechnology sector into the red on Wednesday as the drugmaker disappointed with a drop in quarterly sales and its full-year outlook. The company announced at midday that it has slashed its 2014 outlook as it reported a

Avacta Appoints Cosmo Bio As Japanese Distributor For Affimers

Wednesday broker round-up UPDATE

Advanced Computer Software: Panmure Gordon ups target price from 139p to 155p and stays with its buy recommendation. Avacta: Numis shifts target price from 1.9p to 2p and retains a buy recommendation. Balfour Beatty: Westhouse Securities reduces target price from 302p to 220p keeping its neutral r

UK BROKER RATINGS: Morgan Stanley Cuts SABMiller To Equal-Weight

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
NOMURA RAISES REED ELSEVIER PRICE TARGET TO 1050 (975) PENCE - 'BUY'
----------
CITIGROUP CUTS TULLOW OIL PRICE TA

Avacta Gets Funding Award To Support Affirmer Development

LONDON (Alliance News) - Avacta Group PLC Monday said it had secured a funding award from the UK's innovation agency to support it in developing affirmer technology as a potential way of helping develop new cancer treatments. The company is developing affimers, which are engineered alternat

Avacta In Collaboration Deal With UbiQ To Develop Ubiquitin Reagents

LONDON (Alliance News) - Avacta Group PLC Friday said it has signed a collaboration deal with ubiquitylated peptides supplier UbiQ Bio under which the companies will work together to develop reagents that specifically bind to ubiquitin chains. Avacta makes diagnostic tools, consumables and

Avacta collaborates with UbiQ Bio

AIM-listed pharmaceuticals company Avacta Group announced it has signed a collaboration deal with proteins provider UbiQ Bio to build up its chain of ubiquitin Affimers. The group will be providing Avacta with small proteins found in humans and animals to further the firm's development of Affimers

REPEAT: Avacta Raises GBP10.1M In Placing With Additional Option

LONDON (Alliance News) - Avacta Group PLC Wednesday said it has raised GBP10.1 million before expenses through a share placing on 918.2 million shares, which it will use to accelerate the development and commercialisation of Affimers. The shares were placed with both new and existing instit

Avacta Raises GBP10.1M In Share Placing With Additional Option

LONDON (Alliance News) - Avacta Group PLC Wednesday said it has raised GBP10.1 million before expenses through a share placing on 918.2 million shares, which it will use to accelerate the development and commercialisation of Affimers. The shares were placed with both new and existing instit